Changes in the vascular β-adrenoceptor-activated signalling pathway in 2Kidney-1Clip hypertensive rats

British Journal of Pharmacology

Volumn 141, Issue 7, 2004, Pages 1151-1158

  Callera, Glaucia E ^a   Yeh, Ester ^a   Tostes, Rita C A ^a   Caperuto, Luciana C ^a   Carvalho, Carla R O ^a   Bendhack, Lusiane M ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

adrenoceptor; Ca 2+ATPase; cAMP; Channels; Isoprenaline; K ATP; Protein kinase A; Renal hypertension

Indexed keywords

8 BROMO CYCLIC AMP; ADENOSINE TRIPHOSPHATASE (CALCIUM); BETA ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CAFFEINE; CALCIUM; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; FORSKOLIN; GLIBENCLAMIDE; ISOPRENALINE; POTASSIUM CHANNEL BLOCKING AGENT; THAPSIGARGIN; VASODILATOR AGENT;

ANIMAL MODEL; ANIMAL TISSUE; AORTA; AORTA CONSTRICTION; ARTICLE; CALCIUM CELL LEVEL; CALCIUM DEPLETION; CONTROLLED STUDY; DRUG ACTIVITY; GENE EXPRESSION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RENOVASCULAR HYPERTENSION; SIGNAL TRANSDUCTION; VASODILATATION;

8-BROMO CYCLIC ADENOSINE MONOPHOSPHATE; ANIMALS; AORTA, THORACIC; CAFFEINE; CALCIUM-TRANSPORTING ATPASES; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; DISEASE MODELS, ANIMAL; FORSKOLIN; GENE EXPRESSION; GLYBURIDE; HYPERTENSION, RENOVASCULAR; ISOPROTERENOL; KIDNEY; MALE; MEMBRANE PROTEINS; MUSCLE, SMOOTH, VASCULAR; PHENYLEPHRINE; POTASSIUM CHANNELS; RATS; RATS, WISTAR; RECEPTORS, ADRENERGIC, BETA; RNA, MESSENGER; SARCOLEMMA; SIGNAL TRANSDUCTION; THAPSIGARGIN; VASOCONSTRICTION; VASODILATION;

EID: 2342503796     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0705717     Document Type: Article

References (53)

1. ALLEN, S.L., BEECH, D.J., FOSTER, R.W., MORGAN, G.P. & SMALL, R.C. (1985). Electrophysiological and other aspects of the relaxant action of isoprenaline in guinea-pig isolated trachealis. Br. J. Pharmacol., 86, 843-854.
2. ASANO, M., MASUZAWA, K. & MATSUDA, T. (1988). Evidence for reduced beta-adrenoceptor coupling to adenylate cyclase in femoral arteries from spontaneously hypertensive rats. Br. J. Pharmacol., 94, 73-86.
3. ASANO, M., MASUZAWA, K., MATSUDA, T. & ASANO, T. (1991). Decreased responsiveness to β-adrenoceptor agonists in arterial strips from spontaneously hypertensive rats is not associated with alterations in β-adrenoceptors. J. Hypertens., 9, 607-613.
4. BENNETT, M.A., WATTP, A.C. & THURSTON, H. (1993). Impaired endothelium-dependent relaxation in two-kidney, one clip Goldblatt hypertension: effect of vasoconstrictor prostanoids. J. Hypertens., 11 (Suppl. 5), S134-S135.
5. 2+. J. Cardiovasc. Pharmacol., 27, 27-32.
6. BRADFORD, M.M. (1976). A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem., 72, 248-254.
7. CALLERA, G.E. & BENDHACK, L.M. (1999a). Role of endothelium on decreased relaxation to isoprenaline in renal hypertensive rats. Hypertension, 33, 169P.
8. CALLERA, G.E. & BENDHACK, L.M. (1999b). Contribution of sarcoplasmic reticulum uptake and L-type calcium channels to altered vascular responsiveness in the aorta of renal hypertensive rats. Gen. Pharmacol., 33, 457-466.
9. CALLERA, G.E., VARANDA, W.A. & BENDHACK, L.M. (2000). Impaired relaxation to Ach in 2K-1C hypertensive rat aortas involves changes in membrane hyperpolarization instead of an abnormal contribution of endothelial factors. Gen. Pharmacol., 34, 379-389.
10. 2+ influx is increased in 2-kidney, 1-clip hypertensive rat aorta. Hypertension, 38, 592-596.
11. CARDILLO, C., KILCOYNE, C.M., QUYYUMI, A.A., CANNON, R.O. & PANZA, J.A. (1997). Decreased vasodilation response to isoproterenol during nitric oxide inhibition in humans. Hypertension, 30, 918-921.
12. CAUVIN, C. & PEGRAM, B. (1983). Decreased relaxation of isolated mesenteric resistance vessels from two kidney, one-clip Goldblatt hypertensive rats. Clin. Exp. Hypertens., 5, 383-400.
13. CHRUSCINSKI, A., BREDE, M.E., MEINEL, L., LOHSE, M.J., KOBILKA, B.K. & HEIN, L. (2001). Differential distribution of β-adrenergic receptor subtypes in blood vessels of knockout mice lacking β1- or β2-adrenergic receptors. Mol. Pharmacol., 60, 955-962.
14. 2 adrenergic receptor gene. J. Biol. Chem., 274, 16694-16700.
15. DOHI, Y., CRISCIONE, L. & LÜSCHER, T.F. (1991). Renovascular hypertension impairs formation of endothelium-derived relaxing factors and sensitivity to endothelin-1 in resistance arteries. Br. J. Pharmacol., 104, 349-354.
16. ECKHART, A.D., OZAKI, T., TEVAEARAI, H., ROCKMAN, H.A. & KOCH, W.J. (2002). Vascular-targeted overexpression of G protein-coupled receptor kinase-2 in transgenic mice attenuates β-adrenergic receptor signalling and increases resting blood pressure. Mol. Pharmacol., 61, 749-758.
17. ECKLY-MICHEL, A., MARTIN, V. & LUGNIER, C. (1997). Involvement of cyclic nucleotide-dependent protein kinases incyclic AMP-mediated vasorelaxation. Br. J. Pharmacol., 122, 158-164.
18. FUJII, K., ONAKA, U., GOTO, K., ABE, I. & FUJISHIMA, M. (1999). Impaired isoproterenol-induced hyperpolarization in isolated mesenteric arteries of aged rats. Hypertension, 34, 222-228.
19. FUJIMOTO, S., DOHI, Y., AOKI, K. & MATSUDA, T. (1988). Altered vascular beta adrenoceptor-mediated relaxation in deoxycorticosterone-salt hypertensive rats. J. Pharmacol. Exp. Ther., 244, 716-723.
20. GOTO, K., FUJII, K. & ABE, I. (2001). Impaired β-adrenergic hyperpolarization in arteries from prehypertensive spontaneously hypertensive rats. Hypertension, 37, 609-613.
21. GROSS, R., CHORAZYCZEWSKI, J., MEEK, M.D., BENOVIC, J.L., FERGUSON, S.S. & FELDMAN, R.D. (2000). G-protein-coupled receptor kinase activity in hypertension: increased vascular and lymphocyte G-protein receptor kinase-2 protein expression. Hypertension, 35, 38-42.
22. HAYNES, J., ROBINSON, J., SAUNDERS, L., TAYLOR, A.E. & STRADA, S.J. (1992). Role of cAMP-dependent protein kinase in cAMP-mediated vasodilation. Am. J. Physiol., 262, H511-H516.
23. HUANG, Y. & KWOK, K.H. (1998). Beta-adrenoceptor-mediated relaxation inhibited by tetrapentylammonium ions in rat mesenteric artery. Life Sci., 62, 19-25.
24. ITOH, T., IZUMI, H. & KURIYAMA, H. (1982). Mechanisms of relaxation induced by activation of beta-adrenoceptors in smooth muscle cells of the guinea-pig mesenteric artery. J. Physiol., 326, 475-493.
25. KITAZONO, T., HESITAD, D.D. & FARACI, F.M. (1993). ATP-sensitive potassium channels in the basilar artery during chronic hypertension. Hypertension, 22, 677-681.
26. LYTTON, J., WESTLIN, M. & HANLEY, M.R. (1991). Thapsigargin inhibits the sarcoplasmic or endoplasmic reticulum Ca-ATPase family of calcium pumps. J. Biol. Chem., 266, 17067-17071.
27. MARBLE, A. (1971). Glibenclamide, a new sulphonylurea: whither oral hypoglycaemic agents? Drugs, 1, 109-115.
28. MIYOSHI, H. & NAKAYA, Y. (1993). Activation of ATP-sensitive K1-channels by cyclic AMP-dependent protein kinase in cultured smooth muscle cells of porcine coronary artery. Biochem. Biophys. Res. Commun., 193, 240-247.
29. MUNDIÑA-WEILENMANN, C., VITTONE, L., RINALDI, G., SAID, M., CINGOLANI, G.C. & MATTIAZZI, A. (2000). Endoplasmic reticulum contribution to the relaxant effect of cGMP- and cAMP-elevating agents in feline aorta. Am. J. Physiol., 278, H1856-H1865.
30. MURRAY, K.J. (1990). Cyclic AMP and mechanisms of vasodilation. Pharmacol. Ther., 47, 329-345.
31. NAKASHIMA, M. & VANHOUTTE, P.M. (1995). Isoproterenol causes hyperpolarization through opening of ATP-sensitive potassium channels in vascular smooth muscle of the canine saphenous vein. J. Pharmacol. Exp. Ther., 272, 379-384.
32. + channels in mesenteric artery cells from spontaneously hypertensive rats. Hypertension, 27, 1234-1239.
33. OUSTERHOUT, J.M. & SPERELAKIS, N. (1987). Cyclic nucleotides depress action potentials in cultured aortic smooth muscle cells. Eur. J. Pharmacol., 144, 7-14.
34. PUDDU, P., PUDDU, G.M., ZACA, F. & MUSCARI, A. (2000). Endothelial dysfunction in hypertension. Acta Cardiol., 55, 221-232.
35. RANDALL, M.D. & MCCULLOCH, A.I. (1995). The involvement of ATP-sensitive potassium channels in beta-adrenoceptor-mediated vasorelaxation in the rat isolated mesenteric arterial bed. Br. J. Pharmacol., 115, 607-612.
36. RANNELS, S.R. & CORBIN, J.D. (1979). Characterization of small cAMP-binding fragments of cAMP-dependent protein kinases. J. Biol. Chem., 254, 8605-8610.
37. ROHRER, D.K., CHRUSCINSKI, A., SCHAUBLE, E.H., BERNSTEIN, D. & KOBILKA, B.K. (1999). Cardiovascular and metabolic alterations in mice lacking both β1- and β2-adrenergic receptors. J. Biol. Chem., 274, 16701-16708.
38. SADOSHIMA, J., AKAIKE, N., KANAIDE, H. & NAKAMURA, M. (1988). Cyclic AMP modulates Ca-activated K channel in cultured smooth muscle cells of rat aorta. Am. J. Physiol., 255, H754-H759.
39. SATAKE, N., SHIBATA, M. & SHIBATA, S. (1996). The inhibitory effects of iberiotoxin and 4-aminopyridine on the relaxation induced by beta 1- and beta 2-adrenoceptor activation in rat aortic rings. Br. J. Pharmacol., 119, 505-510.
40. SCHIFFRIN, E.L. (2001). A critical review of the role of endothelial factors in the pathogenesis of hypertension. J. Cardiovasc. Pharmacol., 38 (Suppl. 2), S3-S6.
41. SEAMON, K.B. & DALY, J.W. (1981). Forskolin: a unique diterpene activator of cyclic AMP-generating systems. J. Cyclic Nucleotide Res., 7, 201-224.
42. SHERIDAN, B.C., MCINTYRE, R.C., MELDRUM, D.R. & FULLERTON, D.A. (1997). KATP channels contribute to β- and adenosine receptor-mediated pulmonary vasorelaxation. Am. J. Physiol., 273, L950-L956.
43. SOLTIS, E.E. & KATOVICH, M.J. (1991). Reduction in aortic smooth muscle beta-adrenergic responsiveness results in enhanced norepinephrine responsiveness in the Dahl salt-sensitive rat. Clin. Exp. Hypertens., 13, 117-132.
44. STEKIEL, W.J., CONTNEY, S.J. & RUSCH, N.J. (1993). Altered β-receptor control of in situ membrane potential in hypertensive rats. Hypertension, 21, 1005-1009.
45. TADDEI, S. & SALVETTI, A. (2002). Endothelial dysfunction in essential hypertension: Clinical implications. J. Hypertens., 20, 1671-1674.
46. TAKABA, H., NAGAO, T., IBAYASHI, S., KITAZONO, T., FUJII, K. & FUJISHIMA, M. (1996). Altered cerebrovascular response to a potassium channel opener in hypertensive rats. Hypertension, 28, 143-146.
47. 2+ uptake in aorta from deoxycorticosterone acetate hypertensive rats: functional assessment with cyclopiazonic acid. Can. J. Physiol. Pharmacol., 73, 1536-1545.
48. TOUYZ, R.M. (2002). Impaired vasorelaxation in hypertension: beyond the endothelium. J. Hypertens., 20, 371-373.
49. TSUJIMOTO, G., LEE, C.H. & HOFFMAN, B.B. (1986). Age-related decrease in beta adrenergic receptor-mediated vascular smooth muscle relaxation. J. Pharmacol. Exp. Ther., 239, 411-415.
50. VAN DE VOORDE, J., VANHEEL, B. & LEUSEN, I. (1992). Endothelium-dependent relaxation and hyperpolarization in aorta from control and renal hypertensive rats. Circ. Res., 70, 1-8.
51. WATRAS, J. (1988). Regulation of calcium uptake in bovine aortic sarcoplasmic reticulum by cyclic AMP-dependent protein kinase. J. Mol. Cell Cardiol., 20, 711-723.
52. WERSTIUK, E.S. & LEE, R.M.K.W. (2000). Vascular β-adrenoceptor function in hypertension and in aging. Can. J. Physiol., 78, 433-452.
53. WHITE, R., BOTTRILL, F.E., SIAU, D. & HILEY, C.R. (2001). Protein kinase A-dependent and -independent effects of isoproterenol in rat isolated mesenteric artery: interactions with levcromakalim. J. Pharmacol. Exp. Ther., 298, 917-924.